Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin therapy to inhibit progression in patients with abdominal aortic aneurysm
2017-001788-19Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin in abdominal aortic aneurysm (AAA), sponsored by Medical University of Vienna. Primary endpoint: AAA growth at 12 months. Started Aug 2018; status: completed.
02
Drugs
metformin
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on 2017-001788-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001788-19.